VIENNA—Understanding the emerging genomic landscape of breast cancer needed international research including large molecular screening projects—according to Peter Campbell MD PhD, head of Cancer Genetics and Genomics at the Sanger Institute in Cambridge and joint head of the Cancer Genome Project—speaking at the St Gallen Breast Cancer Conference. He gave Oncology Times reporter Sarah Maxwell his insights into how breast cancer genomics can be applied to the clinic.
You may also like...
Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia 6 Aug, 2013 ASCO Audio Journal of Oncology – June 1st, 2006 – In the company of Gordon McVie 30 May, 2006 ASCO Annual Meeting Daily News Podcasts – June 3rd, 2007 4 Jun, 2007 ASCO Audio Journal of Oncology in Advance -July 1st, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007 1 Jul, 2007
- Previous story Deep Genomic Profiling in Breast Cancer Promises to Improve Outcomes
- Next story Tumor Microenvironment: Tumor Infiltrating Lymphocyte Score Predicts Breast Cancer Outcome
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014